| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | GDF 15 as a novel biomarker in patients with IgA nephropathy |
| 저자 | Ki Ryang Na1, Yoo Hyung Kim1, Hyo Kyun Chung1, Min-Kyung Yeo2, Jin Young Jeong1, Koon Soon Kim1, Kang Wook Lee1, Dae Eun Choi* 1 |
| 출판정보 | 2016; 2016(1): |
| 키워드 | GDF15, IgA nephropathy |
| 초록 | Background: No prognostic biomarkers have been identified for IgA nephropathy. Growth differentiation factor 15 (GDF 15) is a member of the transforming growth factor-β superfamily and could be a useful disease severity and prognostic marker in patients with IgA nephropathy. Methods: Patients in a Chungnam National Hospital glomerulonephritis cohort, who were diagnosed with IgA nephropathy from March 2010 to June 2014, were included. Blood samples were stored at –80°C. GDF 15 was analyzed using an enzyme-linked immunosorbent assay. Results: GDF 15 correlated well with initial eGFR (R = −0.649) and mean serum GDF 15 level was correlated with chronic kidney disease (CKD) stage. A GDF 15 level > 496.32 pg/mL showed 90% sensitivity and 72.9% specificity for predicting the need for hemodialysis within 2 years of diagnosis and > 490.4 pg/mL showed 63.64% sensitivity and 65% specificity to predict a decline in eGFR > 30 ml/min in 1 year. In addition, initial serum GDF 15 level was associated with development of interstitial fibrosis/tubular atrophy. Conclusion: Initial serum GDF 15 level was useful as a disease severity and prognostic biomarker in patients with IgA nephropathy. |
| 원문(PDF) | PDF 원문보기 |